Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

OBJECTIVES: To compare best corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) in patients with type 2 macular telangiectasia (MacTel 2) and a control group and to evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Çoban Karataş, Müge, Yılmaz, Gürsel, Yüce Sezen, Aslıhan, Sarıtürk, Çağla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876777/
https://www.ncbi.nlm.nih.gov/pubmed/35196839
http://dx.doi.org/10.4274/tjo.galenos.2021.75608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876777/
https://www.ncbi.nlm.nih.gov/pubmed/35196839
http://dx.doi.org/10.4274/tjo.galenos.2021.75608

Ejemplares similares